In-Silico Riboswitch Based Drug Design for SARS 1

Sonal Nivsarkar and Vishal Bhojyawal

International Journal of Scientific Research in Science and Technology, 2024, vol. 11, issue 4, 15-22

Abstract: Protein from the coronavirus causing severe acute respiratory syndrome (SARS-CoV) is responsible for binding to and identifying amino acid residues that are important for the synthesis of S1 with ACE2. It aids in the creation of antiviral inhibitors and experimental research. Anatomical models of the SARS-CoV S1 protein in fuse with human ACE2 were created in this study. One riboswitch depict for one strain of SARS Virus and five inhibitors have been classified for this riboswitch by virtual screening. These inhibitors seen to be free from the side effects of anti-viral agents.

Keywords: Riboswitch; Virtual Screening; AutoDock; SARS Virus; Inhibitor (search for similar items in EconPapers)
Date: 2024
References: Add references at CitEc
Citations:

Downloads: (external link)
https://ijsrst.com/home/article/view/IJSRST24114102 Abstract page (text/html)
https://ijsrst.com/home/article/download/IJSRST24114102/IJSRST24114102 Full text (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:etm:ijsrst:v11:y2024:i4:id:253

DOI: 10.32628/IJSRST24114102

Access Statistics for this article

More articles in International Journal of Scientific Research in Science and Technology from Technoscience Academy
Bibliographic data for series maintained by Pankaj Sharma ().